ReviewThe benzodiazepine (cas 12794-10-4) Binding Sites of GABAA Receptors
-
Add time:08/31/2019 Source:sciencedirect.com
Everyday activity is based on a subtle equilibrium of excitatory and inhibitory neuronal systems. The most prominent players in neuronal inhibition are synaptic and extrasynaptic GABAA receptors. benzodiazepine (cas 12794-10-4)s are popular drugs that act as positive allosteric modulators of a subset of these receptors. Benzodiazepines have sedative, hypnotic, muscle-relaxant, and anticonvulsive effects, and are of outstandingly low overdose risk. The discovery of a large number of subtypes of GABAA receptors has raised hopes for a clear separation of this spectrum of actions. We discuss here how far this separation has been achieved, and outline recent progress towards the discovery of novel ligands for canonical and non-canonical binding sites.
We also recommend Trading Suppliers and Manufacturers of benzodiazepine (cas 12794-10-4). Pls Click Website Link as below: cas 12794-10-4 suppliers
Prev:Review ArticleThe Association Between benzodiazepine (cas 12794-10-4)s and Survival in Patients With Cancer: A Systematic Review
Next:Influence of Abuse History on Concurrent benzodiazepine (cas 12794-10-4) and Opioid Use in Chronic Pain Patients) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Inappropriate prescription of benzodiazepine (cas 12794-10-4)s in acutely hospitalized older patients09/04/2019
- Original StudyAssociation of benzodiazepine (cas 12794-10-4) and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults09/03/2019
- Brief Reportbenzodiazepine (cas 12794-10-4)s vs barbiturates for alcohol withdrawal: Analysis of 3 different treatment protocols09/02/2019
- Influence of Abuse History on Concurrent benzodiazepine (cas 12794-10-4) and Opioid Use in Chronic Pain Patients09/01/2019
- Review ArticleThe Association Between benzodiazepine (cas 12794-10-4)s and Survival in Patients With Cancer: A Systematic Review08/30/2019
- 7New benzodiazepine (cas 12794-10-4)s for sedation08/29/2019
- ReviewAn expanding world of new psychoactive substances—designer benzodiazepine (cas 12794-10-4)s08/28/2019
- ReviewThe epidemiology of benzodiazepine (cas 12794-10-4) misuse: A systematic review08/27/2019


